optiMYOPE – Myopia Management Solution
optiMYOPE – Myopia Management Solution
optiMYOPE
optiMYOPE is a state-of-the-art myopia management solution for paediatric patients who are considered a high risk for myopia progression and its associated pathologies. Using the concept of hyperopic defocus, optiMYOPE has been shown to slow the progression of myopia to reduce the risk of developing conditions such as cataract, glaucoma, retinal detachment and myopic maculopathy.
With clinical trial data to support its efficacy, optiMYOPE is the ideal addition to your myopia management portfolio.
Advantages
- Specifically developed to slow down myopia progression
- Provides full correction in the vertical meridian
- Quick adaptation
- Hyperopic defocus in the horizontal meridian
Share This Story, Choose Your Platform!
The incidence of myopia has been increasing more and more in recent years and it is expected to become one of the leading causes of permanent blindness in the world.
In fact, studies have shown that a 1-dioptre increase in myopia is associated with a 67% increase in the prevalence of myopic maculopathy, the most common and serious sight-threatening complication of myopia and the main cause of irreversible vision loss in the world.
